Search

Carla V Finkielstein

from Blacksburg, VA
Age ~56

Carla Finkielstein Phones & Addresses

  • 202 Mountain Breeze Dr, Blacksburg, VA 24060 (540) 953-0107
  • 1225 Birch St, Denver, CO 80220 (303) 377-9871

Work

Company: Virginia tech Position: Assistant professor

Education

Degree: Doctorates, Doctor of Philosophy School / High School: Duke University 1979 to 1982 Specialities: Philosophy

Industries

Research

Resumes

Resumes

Carla Finkielstein Photo 1

Assistant Professor

View page
Location:
202 Mountain Breeze Dr, Blacksburg, VA 24060
Industry:
Research
Work:
Virginia Tech
Assistant Professor
Education:
Duke University 1979 - 1982
Doctorates, Doctor of Philosophy, Philosophy

Publications

Us Patents

Compounds And Methods For Inhibiting The Metastasis Of Cancer Cells

View page
US Patent:
20120264212, Oct 18, 2012
Filed:
Nov 5, 2010
Appl. No.:
13/508255
Inventors:
Daniel G. S. Capelluto - Blacksburg VA, US
Carla V. Finkielstein - Blacksburg VA, US
John D. Welsh - Pennington NJ, US
Assignee:
Virginia Tech Intellectual Properties, Inc. - Blacksburg VA
International Classification:
C12N 5/09
US Classification:
435375
Abstract:
The present invention relates to compounds and methods for inhibiting cancer metastasis. In an embodiment, the compound of the present invention contains the sulfatide binding region of the terminal phosphotyrosine binding domain (N-PTB) of Disabled-2 (Dab2).

Compounds And Methods For Inhibiting Platelet Aggregation

View page
US Patent:
20100285583, Nov 11, 2010
Filed:
May 7, 2010
Appl. No.:
12/775834
Inventors:
Daniel G.S. Capelluto - Blacksburg VA, US
Carla V. Finkielstein - Blacksburg VA, US
Karen E. Drahos - Fort Wayne IN, US
John D. Welsh - Pennington NJ, US
International Classification:
C12N 5/078
C07K 7/00
C07K 7/06
C07K 7/08
C07K 14/47
C07H 21/00
C12N 1/21
US Classification:
435375, 530327, 530329, 530328, 530330, 530326, 530350, 536 235, 43525233
Abstract:
The present invention relates to compounds and methods for inhibiting platelet aggregation. In an embodiment, the compound of the present invention contains the sulfatide binding region of the N-terminal phosphotyrosine binding domain (N-PTB) of Disabled-2 (Dab2).
Carla V Finkielstein from Blacksburg, VA, age ~56 Get Report